Phlegmasia cerulea dolens as a complication of deep vein thrombosis in a man with primary antiphospholipid syndrome

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 8, 2005, Pages 567-569

  Padjas, Agnieszka ^a   Brzezinska Kolarz, Beata ^a   Undas, Anetta ^a   Musial, Jacek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antiphospholipid syndrome; Deep vein thrombosis; Lupus anticoagulant; Phlegmasia cerulea dolens

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; DIURETIC AGENT; ENOXAPARIN; HEPARIN; LUPUS ANTICOAGULANT; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMORBIDITY; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; HUMAN; LABORATORY TEST; LEG; MALE; PHLEGMASIA CERULEA DOLENS; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 27844434664     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000191910.24780.81     Document Type: Article

References (12)

1. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42:1309-1311.
2. Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000; 43:440-443.
3. Asherson RA, Cervera R. 'Primary', 'secondary' and other variants of the antiphospholipid syndrome. Lupus 1994; 3:293-298.
4. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74:1185-1190.
5. Baethge BA, Payne DK. Phlegmasia cerulea dolens associated with the lupus anticoagulant. West J Med 1991; 154:211-213.
6. Hanly JG. Antiphospholipid syndrome: an overview. Can Med Assoc J 2003; 168:1675-1682.
7. Simioni P, Prandoni P, Zanon E, Saracino MA, Scudeller A, Villalta S, et al. Deep venous thrombosis and lupus anticoagulant. A case-control study. Thromb Haemost 1996; 76:187-189.
8. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101:1827-1832.
9. Eschwege V, Peynaud-Debayle E, Wolf M, Amiral J, Vissac AM, Bridey F, et al. Prevalence of antiphospholipid-related antibodies in unselected patients with history of venous thrombosis. Blood Coagul Fibrinolysis 1998; 9:429-434.
10. Lau CP, Leung WH, Wong CK, Cheng CH. Venous gangrene (phlegmasia caerulea dolens) complicating heart failure from severe mitral stenosis - a case history. Angiology 1991; 42:654-658.
11. Lorimer JW, Semelhago LC, Barber GG. Venous gangrene of the extremities. Can J Surg 1994; 37:379-384.
12. Perkins JM, Magee TR, Galland RB. Phlegmasia caerulea dolens and venous gangrene. Br J Surg 1996; 83:19-23.